Clinical trials: Nipple Graft Loss
Nipple Necrosis, Nipple Graft Loss
Plexaa For Preconditioning: Gender Affirming Mastectomy
The goal of this clinical trial is to evaluate the use of the Plexaa preconditioning device (BLOOM43) in transgender and non-binary patients undergoing gender affirming mastectomy.
- Trial name
- P4PGAM (NCT06502353)
- Testing
- BLOOM43
- Where
- United States
- Volunteers
- 15 people
- Sponsor
- Plexaa Ltd